Characteristics | Men (n = 892) | Women (n = 1240) | ||||
---|---|---|---|---|---|---|
No vertebral fracture (n = 771) | Vertebral fracture (n = 121) | P | No vertebral fracture (n = 1079) | Vertebral fracture (n = 161) | P | |
Age (years) | 67.4 (7.6) | 70.4 (7.5) | <0.001 | 67.3 (7.1) | 71.3 (7.6) | <0.001 |
Body height (cm) | 175.1 (6.5) | 174.2 (6.9) | 0.182 | 162.1 (6.1) | 160.3 (7.1) | 0.001 |
Body weight (kg) | 83.9 (12.1) | 82.9 (11.7) | 0.371 | 71.0 (12.4) | 68.8 (12.4) | 0.039 |
Hip bone mineral density (BMD) (g/cm2)a | 1.027 (0.142) | 0.973 (0.161) | <0.001 | 0.901 (0.130) | 0.830 (0.115) | <0.001 |
Smoking | 0.491 | 0.421 | ||||
Current | 13.6% (105) | 17.4% (21) | 17.5% (189) | 19.3% (31) | ||
Past | 61.6% (753) | 57.0% (69) | 41.5% (448) | 36.0% (58) | ||
Never | 24.8% (191) | 25.6% (31) | 41.0% (443) | 44.7% (72) | ||
Physical inactivityb | 20.4% (141) | 17.4% (19) | 0.661 | 19.7% (181) | 18.8% (26) | 0.947 |
Cardiovascular diseasec | 22.6% (174) | 24.0% (29) | 0.733 | 10.1% (109) | 15.5% (25) | 0.038 |
Lung diseased | 11.2% (86) | 18.2% (22) | 0.028 | 14.8% (160) | 12.4% (20) | 0.421 |
Hormone drugs for menopausee | 7.7% (76) | 4.6% (6) | 0.193 | |||
Corticosteroid use | 5.8% (45) | 11.6% (14) | 0.018 | 8.3% (90) | 9.3% (15) | 0.678 |
FVC (liter (SE)) | 4.20 (0.81) | 4.00 (0.86) | 0.014 | 2.95 (0.56) | 2.77 (0.64) | <0.001 |
FEV1 (liter (SE)) | 3.05 (0.70) | 2.82 (0.79) | 0.001 | 2.18 (0.48) | 2.02 (0.55) | <0.001 |
FEV1/FVC (% (SD)) | 72.5 (8.7) | 69.9 (10.5) | 0.003 | 73.8 (7.4) | 72.5 (8.4) | 0.046 |